Ralph Baric

Professor

University of North Carolina at Chapel Hill

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Ralph Baric is a Professor at the University of North Carolina at Chapel Hill, United States. His research areas include virology, with a focus on the molecular evolution and epidemiology of various viruses, including Zika, SARS-CoV-2, and noroviruses. Recent articles by Baric explore the impacts of viral infections on the immune response and potential vaccine developments.

Articles (20)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (25)

Long Ping Victor Tse

Assistant Professor

Saint Louis University

UNITED STATES

Ralph Baric

Research Interests

Explore related searches

Contact this professor

About

Articles (20)

Envelope-dimer epitope 1 (EDE1) antibody (C10) treatment significantly reduces Zika virus replication in the male and female reproductive tracts

ACE2 from Pipistrellus abramus bats is a receptor for HKU5 coronaviruses

Stabilized dengue virus 2 envelope subunit vaccine redirects the neutralizing antibody response to all E-domains

Effector CD8 T cell differentiation in primary and breakthrough SARS-CoV-2 infection in mice

Molecular Evolution and Epidemiology of Norovirus GII.4 Viruses in the United States

Efficacy of host cell serine protease inhibitor MM3122 against SARS-CoV-2 for treatment and prevention of COVID-19

Host Genetic Variation Impacts SARS-CoV-2 Vaccination Response in the Diversity Outbred Mouse Population

Animal models of Long Covid: A hit-and-run disease

A Bivalent Human Norovirus Vaccine Induces Homotypic and Heterotypic Neutralizing Antibodies

Erratum for Chan et al., “Tropism of and Innate Immune Responses to the Novel Human Betacoronavirus Lineage C Virus in Human Ex Vivo Respiratory Organ Cultures”

Targeting spike glycans to inhibit SARS-CoV2 viral entry

Dynamics of SARS-CoV-2 VOC Neutralization and Novel mAb Reveal Protection against Omicron

Stopping pandemics before they start: Lessons learned from SARS-CoV-2

A C57BL/6 Mouse Model of SARS-CoV-2 Infection Recapitulates Age- and Sex-Based Differences in Human COVID-19 Disease and Recovery

Mouse Adapted SARS-CoV-2 (MA10) Viral Infection Induces Neuroinflammation in Standard Laboratory Mice

Norovirus Infection in Young Nicaraguan Children Induces Durable and Genotype-Specific Antibody Immunity

Generation of Mature DENVs via Genetic Modification and Directed Evolution

Antigenic Site Immunodominance Redirection Following Repeat Variant Exposure

Vaccine-induced antibodies to contemporary strains of dengue virus type 4 show a mechanistic correlate of protective immunity

Defining the risk of SARS-CoV-2 variants on immune protection

Collaborators (25)

Long Ping Victor Tse

Paul K. Drain

Barry Rockx

Michael Davis

Zandrea Ambrose

Liliana Brown

Alexander L. Greninger

Michael Letko

Pamela Bjorkman

William Buchser

Nadja Vielot

Timothy Bell

Adrianus C. M. Boon

David Allen

Elodie Ghedin

Derek Smith

Jan Vinje

Michael Gale

Warren Ladiges

Marulasiddappa Suresh

Shreeram Akilesh

Anna Wald

Erica Ollmann Saphire

Tomer Hertz

Jay Kolls

Make your next move.